Retinal tears and detachments are common in PVD and VH patients

Article

Rate of retinal tears (RT) and detachments are higher in patients with an acute posterior vitreous detachment (PVD) and vitreous haemorrhage (VH) patients taking anticoagulants.

Rate of retinal tears (RT) and detachments are higher in patients with an acute posterior vitreous detachment (PVD) and vitreous haemorrhage (VH) patients taking anticoagulants, according to an investigation published in Eye.

Dr A. El-Sanjouri et al., Cincinnati Eye Institute, Cincinnati, Ohio, USA, studied 260 eyes of 260 patients presenting with an acute PVD and VH. All participants were divided into either those taking systemic anticoagulants and those not taking anticoagulants. Patients were examined for evidence of an RT and retinal detachment (RD). Out of the whole cohort, 137 took anticoagulants (Group 1) and 123 were not taking anticoagulants (Group 2).

In group 1 it was found that 46% of patients had an RT, compared to 72% in group 2. RDs were found in 23% of group 1 patients and 37% in group 2.

PVD and VH patients using anticoagulants experienced a higher rate of RTs and RDs than those who didn't take anticoagulants. The study suggests anticoagulation status could be a significant factor to consider for the occurrence of an RT or RD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.